AMC
Tiny target bump, same old bear case
AMC managed to catch a modest analyst update on Friday: Citigroup’s Jason Bazinet kept a Sell rating on the theater chain while lifting the 12-month price target from $1.80 to $2.20. In other words, the stock got a slightly less gloomy forecast, but not exactly a standing ovation.
Why the stock still looks wobbly
Bazinet’s logic is pretty classic AMC: the box office has improved a bit, but not enough to erase the company’s bigger problems. The theater business is still fighting:
- Leverage that feels like a backpack full of bricks
- The risk of more shareholder dilution
- Attendance trends that still aren’t back to pre-pandemic glory
That cocktail matters because AMC needs better ticket volumes to get real operating leverage, and right now the math still looks messy.
The debt monster is still in the room
Even with a tiny target hike, the market is staring at the same thing it always does with AMC: debt, interest expense, and the possibility the company keeps reaching for financing tools like debt-for-equity swaps or at-the-market stock sales. That’s not exactly the kind of setup that makes investors race to buy the dip.
Big picture: AMC got a softer slap from Citi, not a clean bill of health. The stock may bounce around, but the same old balance-sheet drama keeps the ceiling low.